Perspective: Pivotal translational hematology and therapeutic insights in chronic myeloid hematopoietic stem cell malignancies
Year: 2022
Type: review
Abstract: Despite much of the past 2 years being engulfed by the devastating consequences of the SAR-CoV-2 pandemic, significant progress, even breathtaking, occurred in the field of chronic myeloid malignancies. Some of this was show-cased at the 15th Post-American Society of Hematology (ASH) and the 25th John Goldman workshops on myeloproliferative neoplasms (MPN) held on 9th-10th December 2020 and 7th-10th October 2021, respectively. The inaugural Post-ASH MPN workshop was set out in 2006 by John Goldman (deceased) and Tariq Mughal to answer emerging translational hematology and therapeutics of patients with these malignancies. Rather than present a resume of the discussions, this perspective focuses on some of the pivotal translational hematology and therapeutic insights in these diseases.
Source: Hematological Oncology
DOI: 10.1002/hon.2987
Authors: Tariq I. Mughal, Naveen Pemmaraju, Rafael Bejar, Robert P. Gale, Prithviraj Bose, Jean‐Jacques Kiladjian, Josef Prchal, Daniel Royston, Daniel Pollyea, Peter Valent, Tim H. Brümmendorf, Tomasz Skorski, Mrinal Patnaik, Valeria Santini, Pierre Fenaux, Nicole Kucine, Srdan Verstovsek, Ruben Mesa, Tiziano Barbui, Guiseppe Saglio, Richard A. Van Etten
Institutions: Tufts University, University of Buckingham, The University of Texas MD Anderson Cancer Center, University of California San Diego, Imperial College London, Inserm, Hôpital Saint-Louis, Huntsman Cancer Institute, John Radcliffe Hospital, University of Oxford, University of Colorado Anschutz, Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Universitätsklinikum Aachen, RWTH Aachen University, Temple University, Mayo Clinic, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Assistance Publique – Hôpitaux de Paris, Weill Cornell Medicine, The University of Texas at San Antonio Health Science Center, Mays Cancer Center at UT Health San Antonio, FROM – Fondazione per la Ricerca Ospedale di Bergamo ETS, University of Turin, University of California, Irvine
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: Cancer Research UK
Award: G1005480105
OpenAlex ID: W4223942277